Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety, and efficacy in the first year of clinical practice

Stroke

Volumn 29, Issue 1, 1998, Pages 18-22

  Chiu, David ^a   Krieger, Derk ^b   Villar Cordova, Carlos ^b   Kasner, Scott E ^b   Morgenstern, Lewis B ^b   Bratina, Patti L ^b   Yatsu, Frank M ^b   Grotta, James C ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Cerebral hemorrhage; Cerebral infarction; Emergency medical services; Thrombolytic therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ENALAPRIL; HEPARIN; LABETALOL; NICARDIPINE; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; EMERGENCY WARD; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PHASE 4 CLINICAL TRIAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031963837     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.1.18     Document Type: Article

References (15)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
2. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, Hennerici M, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
3. Donnan GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, McNeil JJ, Rosen D, Stewart-Wynne EG, Tuck RR, for the Australian Streptokinase (ASK) Trial Study Group. Streptokinase for acute ischemic stroke with relationship to time of administration. JAMA. 1996;276:961-966.
4. The Multicenter Acute Stroke Trial - Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med. 1996;335:145-150.
5. The Multicentre Acute Stroke Trial - Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischemic stroke. Lancet. 1995;346:1509-1514.
6. Hacke W, Toni D, Steiner T, Kaste M, von Kummer R, Fieschi C, Bluhmki E for the ECASS Study Group. Rt-PA in acute ischemic stroke: results from the ECASS three-hour cohort. Stroke. 1997;28:272. Abstract.
7. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, and the TOAST Investigators. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke. 1993;24:35-41.
8. Shinar D, Gross CR, Bronstein KS, Licata-Gehr EE, Eden DT, Cabrera AR, Fishman IG, Roth AA, Barwick JA, Kunitz SC. Reliability of the activities of daily living scale and its use in the telephone interview. Arch Phys Med Rehabil. 1987;68:723-728.
9. Candelise L, Pinardi G, Aritzu E, Musicco M. Telephone interview for stroke outcome assessment. Cerebrovasc Dis. 1994;4:341-343.
10. Hosmer DW, Lemeshow S. Model-building strategies and methods for logistic regression. In: Hosmer DW, Lemeshow S, eds. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989:82-134.
11. Bratina P, Greenberg L, Pasteur W, Grotta JC. Current emergency department management of stroke in Houston, Texas. Stroke. 1995;26: 409-414.
12. The National Institute of Neurological Disorders and Stroke. A National Symposium on Rapid Identification and Treatment of Acute Stroke, December 12-13, 1996, Arlington, Va.
13. Fagan SC, Morgenstern LB, Petitta A, Ward RE, Tilley BC, Marler JR, Broderick JP, Levine SR, Kwiatkowski T, Frankel M, Walker MD, and the NINDS rt-PA Stroke Study Group. rt-PA reduces length of stay and improves disposition following stroke. Stroke. 1997;28:272. Abstract.
14. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA stroke trial. Stroke. 1997;28:2119-2125.
15. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997;28:2109-2118.